Medical Condition News

RSS

Randox launches automated laboratory assay for Heart-type Fatty Acid Binding Protein

Randox Laboratories, the international clinical diagnostics company, has today launched an automated laboratory assay for Heart-type Fatty Acid Binding Protein (H-FABP), to improve the diagnosis and management of patients with suspected acute coronary syndrome (ACS).

From Randox Laboratories Ltd. 20 Jun 2011

Boston Scientific to launch Mustang PTA Balloon Catheter worldwide

Boston Scientific Corporation today announced the global launch of its Mustang™ PTA Balloon Catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures. The Company plans to launch the product immediately in the U.S., Europe and other international markets.

20 Jun 2011

Spectrum announces various clinical studies on ZEVALIN at ICML 2011

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that various studies on ZEVALIN for Injection were presented at the 11th International Conference on Malignant Lymphoma (ICML), held June 15-18, 2011, in Lugano, Switzerland.

20 Jun 2011

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Pfizer Inc. and Acura Pharmaceuticals Inc. announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTATM Tablets CII.

20 Jun 2011

Concert to advance CTP-499, C-21191 into Phase 2 trials for diabetic nephropathy and spasticity

Concert Pharmaceuticals, Inc. announced today the advancement of two programs from its DCE Platform. CTP-499 is progressing into Phase 2 clinical trials for diabetic nephropathy and C-21191 has been selected as a lead candidate for spasticity.

20 Jun 2011

AARP, Philadelphia Department of Recreation to host outdoor Health and Wellness event

AARP and the Philadelphia Department of Recreation will be hosting an outdoor Health and Wellness event on Monday June 20, 2011 from 12:00 pm- 2:00 pm at Love Park in Center City Philadelphia.

20 Jun 2011

Endo Pharmaceuticals, Jubilant achieve milestone in cancer drug development program

Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo Pharmaceuticals, of Chadds Ford, Pa, U.S.A., announced today that they have achieved a late stage discovery milestone in their joint program focused on cancer.

20 Jun 2011

GTx commences Capesaris Phase IIb trial in advanced prostate cancer

GTx, Inc., announced today that it initiated a Phase IIb clinical trial evaluating Capesaris, a selective estrogen receptor alpha agonist, compared to Lupron Depot for first line treatment of advanced prostate cancer.

20 Jun 2011

GPs struggle to correctly identify patients with early dementia

New research from the University of Leicester demonstrates that general practitioners (GPs) are struggling to correctly identify people in the early stages of dementia resulting in both missed cases and misidentifications.

20 Jun 2011

Ground breaking treatment for Cystic Fibrosis

An international research team led by Queen's University have developed a ground breaking treatment for Cystic Fibrosis sufferers. The new drug will benefit sufferers who have the 'Celtic Gene', a genetic mutation which is particularly common in Ireland.

20 Jun 2011

Alexion begins eculizumab clinical trial in Shiga-toxin producing E. coli hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl (APIS), announced today that the Paul-Ehrlich-Institut, Germany's healthcare regulatory body for biological products, has authorized initiation of an open-label clinical trial to investigate eculizumab as a treatment for patients with Shiga-toxin producing E. coli hemolytic uremic syndrome, which has resulted from infections by Enterohemorrhagic Escherichia coli in an unusually wide outbreak in Germany that began in May.

20 Jun 2011

Patients who receive poorly co-ordinated care more likely to report medication, treatment errors

Patients who received poorly co-ordinated care or were unable to afford basic medical costs were much more likely to report medication, treatment or care errors, according to an international study published in the July issue of IJCP, the International Journal of Clinical Practice.

20 Jun 2011

One in ten Europe's middle-aged citizens took antidepressants during 2010

New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.

20 Jun 2011

Study: Dyslexia gene controls cilia in brain neurons

Scientists at Karolinska Institutet in Sweden have discovered that a gene linked to dyslexia has a surprising biological function: it controls cilia, the antenna-like projections that cells use to communicate.

20 Jun 2011

Targeting activity of PKD1 may be beneficial for treatment of polycystic kidney, liver disease

A single gene is central in the development of several forms of polycystic kidney and liver disease, Yale School of Medicine researchers report in the June 19 issue of Nature Genetics.

20 Jun 2011

University of Texas professor recommends three postulates to find probable cause of AD

After more than 100 years following its pathologic description, the cause of Alzheimer's disease (AD) remains unknown. To test the validity of present and future proposals related to the probable cause of AD, three postulates, or necessary conditions, are recommended by Jack de la Torre, MD, PhD, Adjunct Professor of Psychology at the University of Texas, Austin, in an article published in the Journal of Alzheimer's Disease.

20 Jun 2011

News media and childhood obesity

Where you get your news could play a significant role in determining what you perceive as the best strategy for addressing childhood obesity. According to a study led by researchers from the Johns Hopkins Bloomberg School of Public Health, whether you believe the keys to combating childhood obesity are personal factors such as individual behavior changes or system-level factors such as marketing and the environment may depend on your primary news source.

20 Jun 2011

Medical Condition News

Randox launches automated laboratory assay for Heart-type Fatty Acid Binding Protein

Boston Scientific to launch Mustang PTA Balloon Catheter worldwide

Spectrum announces various clinical studies on ZEVALIN at ICML 2011

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Concert to advance CTP-499, C-21191 into Phase 2 trials for diabetic nephropathy and spasticity

AARP, Philadelphia Department of Recreation to host outdoor Health and Wellness event

Endo Pharmaceuticals, Jubilant achieve milestone in cancer drug development program

GTx commences Capesaris Phase IIb trial in advanced prostate cancer

GPs struggle to correctly identify patients with early dementia

Ground breaking treatment for Cystic Fibrosis

Alexion begins eculizumab clinical trial in Shiga-toxin producing E. coli hemolytic uremic syndrome

Patients who receive poorly co-ordinated care more likely to report medication, treatment errors

One in ten Europe's middle-aged citizens took antidepressants during 2010

Study: Dyslexia gene controls cilia in brain neurons

Targeting activity of PKD1 may be beneficial for treatment of polycystic kidney, liver disease

University of Texas professor recommends three postulates to find probable cause of AD

News media and childhood obesity

Novel biomarker-development pipeline approach for human diseases

NOCSAE receives $1.1M research grants to advance science of sports medicine

Zilver PTX stent more effective than PTA for treatment of femoral artery lesions

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News